Latest Enzyme inhibitor Stories
Dehydrons are defects in protein structure that promote protein associations.
Scientists at The Scripps Research Institute have developed chemical compounds that can make key modifications to common sugar molecules ("glycans"), which are found on the surface of all cells in our body.
In a technical tour de force, scientists at Fox Chase Cancer Center have cataloged and cross-indexed the actions of 178 candidate drugs capable of blocking the activity of one or more of 300 enzymes, including enzymes critical for cancer and other diseases.
Cancer researchers at UT Southwestern Medical Center are helping unlock the cellular-level function of the telomerase enzyme, which is linked to the disease's growth.
Virtually all processes in the human body rely on a unique class of proteins known as enzymes.
If common anticonvulsant drugs fail to manage epileptic seizures, then perhaps the anti-inflammatory* route is the way to go.
Avila Therapeuticsâ„¢, Inc., a biotechnology company developing novel targeted covalent drugs, has published research in Nature Chemical Biology demonstrating the first-ever selective irreversible inhibition of a viral protease using a targeted covalent drug.
- The governor of a province or people.